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The role of pericytes in the control of blood-brain barrier (BBB) integrity has remained enigmatic. In this issue,
Bell et al. and two concurrent studies highlight that pericyte loss causes BBB breakdown and hypoperfusion.
Remarkably, these vascular changes precede neurodegeneration and cognitive defects in old age.In order to function properly, neurons
must maintain their microenvironment
under tight homeostatic control. There-
fore, they are sealed off from the rest of
the organism by a ‘‘blood-brain barrier’’
(BBB). It has been long assumed that
this physical barrier is created largely
by endothelial cells (ECs) in the central
nervous system (CNS), while the role of
pericytes (PCs), i.e., mural cells that
surround and stabilize these vessels, has
remained more enigmatic. In fact, it has
been hypothesized that astrocytes, which
are also part of the neurovascular unit,
are more important in inducing this
barrier. Furthermore, although multiple
neurodegenerative disorders are charac-
terized by vascular anomalies, it has
remained puzzlingwhether these vascular
changes are cause or consequence of the
neurological disease. In this issue, Bell
et al. (2010) report that a progressive
age-dependent loss of PCs around brain
microvessels impairs brain perfusion,
disturbs vasoreactivity, and induces path-
ological BBB leakiness, altogether lead-
ing to neuronal damage, learning deficits,
neurodegeneration and neuroinflamma-
tion during aging. Coincidently, two other
papers in Nature report complementary
findings that PCs are more important
than expected in establishing the BBB
during development and in maintaining
the BBB integrity in adulthood (Armulik
et al., 2010; Daneman et al., 2010). Three
papers thus independently show that PCs
are not simply passive bystanders in the
CNS but actively contribute as critical
gatekeepers to safeguard the neuronal
milieu (Figure 1).
More than a century ago, Paul Ehrlich
(1885) discovered that dyes, injectedinto the blood, accumulated in most
organs except in the brain (Dı´az-Flores
et al., 2009). Based on this seminal obser-
vation, it was postulated that a BBB
shielded the brain from toxic circulating
substances. The BBB constitutes a phys-
ical, metabolic, and transport barrier, re-
stricting traffic of nutrients and other
molecules in and out the brain. One of
the primary functions of the BBB is to
maintain the ionic homeostasis around
synapses. In fact, preserving this ionic
microenvironment is believed to repre-
sent the evolutionary selective pressure
and advantage for developing a barrier
in the nervous system (Abbott, 2005).
In avascular invertebrates, such as
insects and crustaceans, the BBB is
formed by glial cells. Later in evolution,
when the brain enlarged in size and
became more active, blood vessels de-
veloped to nourish every neuron with its
own supply. However, as a possible
consequence of this vascularization, sy-
napses would become exposed to sub-
stances in the blood and thereby lose their
ionic homeostasis. To protect neurons, it
was thus necessary that ECs took over
the role of glial cells as ‘‘first-line’’ barrier
and established BBB properties (Abbott,
2005). While most previous studies have
focused on the role of ECs and astrocytes
in the control of the BBB, the in vivo role of
PCs in the maintenance of the BBB and in
preserving the synaptic homeostasis in
adulthood has remained elusive.
But what sort of cells are PCs precisely,
and what is their role in establishing the
BBB? Derived from the Greek word ‘‘ky-
tos’’ (hollow vessel), pericytes surround
small vessels. Originally discovered by
Rouget in the late 1800s, PCs ensheathNeuron 68,ECs and lie embedded in a basement
membrane, which they share with ECs
(Zlokovic, 2008). They have an elongated
stellate-shape, extend fingertip-like pro-
cesses that cover adjacent ECs in an
umbrella-like fashion, and establish close
physical interactions via peg-socket con-
tacts (Dı´az-Flores et al., 2009). Outside
the brain, PCs originate from mesen-
chymal progenitors, but within the brain,
they arise from the neural crest as well.
Interestingly, vessel coverage by PCs is
greater in tissues with a slow EC turnover
and is the highest in the CNS (Dı´az-Flores
et al., 2009; Zlokovic, 2008). PCs are
multitasking cells with a remarkable plas-
ticity and range of activities: they promote
vessel stabilization by providing structural
integrity and inducing EC quiescence;
they regulate vascular tone and tissue
perfusion; and they can also act as mac-
rophage-like scavengers and serve as
progenitors of various cell types, in-
cluding of neurons and astrocytes
in vitro. However, it was not known
whether PCs are critical to maintain the
BBB integrity in adulthood and, con-
versely, whether PC deficiency would
result in functional neuronal deficit.
For nascent vessels tomature,ECsmust
become covered by PCs and therefore
release signals to recruit PCs. Platelet-
derived growth factor B (PDGF-B) is an
important recruitment cue for PCs, which
express the PDGFRß receptor. Hence,
various types of PDGF(Rß) mutant mice
lack PCs to variable extents. For instance,
PDGF-B/ or PDGFRß/ embryos die
during development because they lack
PCs completely in the CNS and can only
form irregular and aneurysmatic vessels,
which are fragile, leaky, and prone toNovember 4, 2010 ª2010 Elsevier Inc. 321
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Figure 1. Crucial Role of Pericytes in BBB Integrity and Brain Perfusion
(Top) In healthy conditions, pericytes release molecules to brain endothelial cells in order to maintain the
BBB integrity in adulthood. Pericytes also secure normal perfusion and vasoregulation.
(Bottom) Upon pericyte loss, vessels regress and loose their vasoreactivity, leading to hypoperfusion and
hypoxia. In addition, the BBB breaks down, possibly as a result of abnormal endothelial junctions, trans-
cytosis, and astrocyte polarization, resulting in leakage of neurotoxic substances. Both mechanisms
precede neuronal damage.
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dahl et al., 1997). PDGF-B retention motif
knockout mice (PDGF-Bret/ret) with disrup-
ted PDGF-B binding to heparin-richmatrix
or mice lacking PDGF-B selectively in their
ECs have fewer PCs and exhibit signs of
excessive vessel growth in the retina,
similar to diabetic retinopathies (Enge
et al., 2002; Gaengel et al., 2009; Lindblom
et al., 2003).Mice expressingPDGF-Bonly
in ECs (R26+/0) (Armulik et al., 2010) or
PDGFRßF7/F7 mice, homozygous for 7
signaling mutations (Tallquist et al., 2003),
also have fewer PCs. PDGFRß signaling
is of general importance for PC recruitment
in other organs as well (Gaengel et al.,
2009).
Daneman et al. (2010) report that the
BBB develops early during embryogen-322 Neuron 68, November 4, 2010 ª2010 Elsesis before astrocytes are present and
show that, in the absence of PCs in
PDGFRß/ embryos or in the presence
of fewer PCs in PDGFRßF7/F7 neonatal
mice, the BBB is leaky due to abnormal
transcytosis of macromolecules across
the brain endothelium. Using the R26+/0
and PDGF-Bret/ret strains, Armulik et al.
(2010) noticed that partial PC deficiency
in young adult mice similarly causes
macromolecular permeability through
a transcytosis route. Bell et al. (2010)
extend these findings by showing that
adult PDGFRß+/ and PDGFRßF7/F7 mice
progressively lose their PCs in the brain
and develop a progressive age-depen-
dent breakdown of the BBB, which leads
to the perivascular accumulation of
plasma-derived proteins as well asevier Inc.deposits of fibrin and hemosiderine. The
BBB disruption in the latter PDGFR-
signaling mutant mice was not caused
by perfusion deficits, asMeox-2-haplode-
ficient mice, which display a perfusion
deficit because of impaired angiogenesis,
have a normal BBB integrity.
Bell et al. (2010) also noticed another
progressive age-dependent defect in their
PDGFRß mutant mice, i.e., vascular
regression leading to hypoperfusion and
insufficient oxygenation of brain regions.
This regression presumably occurs
because ECs in these PC-deficient mice
are deprived of trophic support from PC-
produced molecules, such as VEGF, an-
giopoietin-1, and others, known to
promote EC survival (Krueger and Bech-
mann, 2010). In addition, vasoregulation
in the brain was also impaired in the
PDGFRß hypomorph strains. Thus, upon
progressive disappearance of PCs, both
structural and functional vessel defects
impair perfusion and oxygenation of
the CNS.
What are the long-term consequences
of the progressive BBB leakiness and
perfusion deficit? Similar vascular defects
have been reported in various types of
neurodegenerative disorders, but, in
many cases, it is uncertain if these
changes are cause or consequence of
the disease (Quaegebeur and Carmeliet,
2010). A remarkable finding by Bell et al.
(2010) therefore is that aging mice with
progressive PC loss develop a neurode-
generative phenotype with neuronal loss,
reduced dendritic length and density in
the hippocampus and cortex, and
impaired hippocampal learning and
spatial memory. Since the vascular
changes precede the onset of neurode-
generation by months, the neuronal injury
is likely a consequence of the compro-
mised brain microcirculation and BBB
disruption.
How can vascular abnormalities upon
PC loss trigger neurodegeneration? First,
hypoperfusion impairs oxygen and
nutrient supply. Isolated perfusion de-
fects without accompanying BBB dis-
ruption in Meox-2-haplodeficient mice
sufficed to cause neuron loss, albeit to
a lesser extent than the PC-deficient
models (Bell et al., 2010). Hypoxia impairs
neuronal function and survival and can
facilitate constriction of residual PCs,
thereby further declining perfusion. It is
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Previewsalso likely that, because of the impaired
vasoregulation, nutrient supply cannot
be dynamically adjusted to the changing
metabolic needs (Hamilton et al., 2010).
A second mechanism is that BBB break-
down causes neuronal injury via leakage
of neurotoxic molecules into the brain
parenchyma and impedes clearance of
waste (Zlokovic, 2008). The leakiness
can also result in inflammation and brain
edema, impairing oxygen delivery even
further. Third, diminished production of
neurotrophic factors by PCs may
contribute to neuronal loss. Finally, PCs
are known to possess neural stem cell
capacity in vitro (Krueger and Bechmann,
2010), raising amore speculative question
of whether neuronal regeneration is also
defective in the PC-deficient mice.
These insights are of great importance.
Neurovascular dysfunction is being in-
creasingly documented in a range of
neurodegenerative disorders. For in-
stance, reduced microvessel density,
cerebral hypoperfusion, and impaired
vessel reactivity have been documented
in Alzheimer’s disease (Quaegebeur and
Carmeliet, 2010; Zlokovic, 2008). The
development of an adult-onset motor
neuron disease phenotype in a mouse
with reduced VEGF levels and perfusion
deficits also suggests a causal involve-
ment of chronic vascular insufficiency in
amyotrophic lateral sclerosis (ALS)
(Quaegebeur and Carmeliet, 2010).
Blood-spinal-cord barrier defects have
been also demonstrated in ALS (Zhong
et al., 2008). The Bell et al. (2010) findings
that the vascular defects precede neuro-
degeneration provide an initial answer to
the highly debated question of whether
cerebrovascular defects can causally
contribute to neurodegeneration (Quae-
gebeur and Carmeliet, 2010; Zlokovic,
2008). These three studies also imply
that PC deficiency might perhaps be
a more common denominator of various
sorts of neurovascular disorders than
previously suspected and warrant further
exploration of the role of PCs in human
neurodegeneration, an area of research
that has been largely neglected so far.
As is often the case, these novel data
raise a number of additional questions.
For instance, how do PCs regulate theBBB integrity (Figure 1)? Daneman et al.
(2010) propose thatPCsare not necessary
for the expression of BBB-specific genes
in ECs but that they release a number of
factors (such as angiopoietin-1) to main-
tain the BBB integrity and to suppress
transcytosis. Armulik et al. (2010) also
did not see marked changes in BBB
gene expression but noticed abnormal
polarization of astrocyte end-feet, sug-
gesting that PCs, which are partially sand-
wichedbetweenECsandastrocytes in the
neurovascular unit, orchestrate bidirec-
tional communications between cells of
the unit. In contrast, Bell et al. (2010) docu-
mented an age-dependent downregula-
tion of several BBB genes but no differ-
ence in astrocyte marker expression. It
remains to be determined whether these
divergent findings are due to differences
in the PDGF(Rß)-deficient strains used,
to technical analysis, or to differences
between development versus aging.
Another question is whether PDGFRß is
truly onlyexpressed inPCsandnot inother
neural cells as well, as loss of PDGFRß in
these cells might then also contribute to
neurodegeneration; genetic studies to
conditionally ablate PDGFRß specifically
in PCs or other cells might help to address
this question. Also, to what extent are the
neurological deficits attributable to neuro-
degeneration or, perhaps, to the vascular
lesions? Indeed, in CADASIL (a human
PC-deficient condition caused by
progressive degeneration of mural cells),
dementia is attributable to vascular micro-
infarcts in the white matter. Are the
observed hypoperfusion and impaired
vasoreactivity only due to a defect in PCs
orarevascular smoothmuscle cells,which
are also targets of PDGF-B and regulate
cerebral flow, in larger arterioles also
affected? Given that PC defects already
appear before birth in several of the
PDGF(Rß)mutant lines used,would condi-
tional ablation of PCs after birth result in
the same neurodegenerative phenotype?
Finally, as the blood-nerve barrier consists
only of PCs (no astrocytes), is the func-
tioning of the peripheral nervous system
impaired in PC-deficient models as well?
The exciting findings that PCs are
active safeguards of the BBB in the neuro-
vascular unit should prime interest in bothNeuron 68,the vascular biology and neuroscience
communities to further study the role of
PCs in neurobiology in general and to
explore the therapeutic potential of
manipulating this intriguing cell type for
neurovascular disorders.REFERENCES
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